Rani Therapeutics Holdings, Inc. (RANI)
1.07
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.08
+0.01
(+0.93%)
After-Hours: 20:00
Rani Therapeutics Holdings EPS Diluted (Quarterly) : -0.0391 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
| IGC Pharma, Inc. | -0.0245 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.015M |
| Revenue (Quarterly) | 1.708M |
| Total Expenses (Quarterly) | 8.741M |
| Enterprise Value | 74.38M |
| Gross Profit Margin (Quarterly) | 90.57% |
| Profit Margin (Quarterly) | -469.3% |
| Earnings Yield | -38.21% |
| Normalized Earnings Yield | -37.95 |